Home
About
Overview
Sharing Data
ORCID
Help
History (29)
Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis.
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis.
Crohn's disease: step up or top down therapy.
A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis.
See All 29 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis.
A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis. Gastroenterology. 2007 Jan; 132(1):76-86.
View in:
PubMed
subject areas
3',5'-Cyclic-AMP Phosphodiesterases
Adolescent
Adult
Aged
Aged, 80 and over
Anti-Inflammatory Agents
Colitis, Ulcerative
Cyclic Nucleotide Phosphodiesterases, Type 4
Female
Humans
Male
Middle Aged
Phosphodiesterase Inhibitors
Placebos
Remission Induction
Sigmoidoscopy
Thiazoles
Treatment Outcome
authors with profiles
Stephen B. Hanauer